MedTrace Logo

Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects

NCT01967147 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 279

Last updated 2016-03-23

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to demonstrate the superior efficacy of Systane® Balance over Preservative-Free 0.9% Saline following 35 days of QID (4 times a day) dosing in treating dry eye subjects with lipid deficiency.

Conditions

  • Dry Eye

Interventions

DRUG

Propylene Glycol, 0.6% eye drops

Commercially available eye drops used during Treatment Phase

DRUG

Preservative-free 0.9% Saline solution

Commercially available solution used as Run-in (1 drop in each eye 4 times a day for 15 days) and during Treatment Phase

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Senior Clinical Manager, GCRA · Alcon Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-01-31
Completion
2015-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01967147 on ClinicalTrials.gov